IG

Ivan Gergel

Managing Partner and Chief Medical Officer, New Rhein Healthcare Investors LLC.

Philadelphia, Pennsylvania

Investor
VC

Invests in

Locations:

Pennsylvania

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Skills

Clinical Trials
Lifesciences
Commercialization
Pharmaceutical Industry
R&D
Clinical Development
Biotechnology
Drug Development
Cross-functional Team Leadership
Clinical Research
Drug Discovery
Drug Delivery
Biopharmaceuticals
CRO
Oncology
Regulatory Affairs
Technology Transfer
Sop
Science
Infectious Diseases

Education

Lists including Ivan

AT
AS
AT
AH

All Series A Investors

14752 people

AM
AT
AS
AR

All Seed Investors

19695 people

Investments

Corsair Pharma

Series B

Total Funding: $23M

Work Experience

CP
Corsair Pharma

2023

  • Chairman of the Board of Directors

    2023

TB
Theranica Bio-Electronics Ltd.

2022

  • Director Board of Directors

    2022

BM
Butterfly Medical

2020

  • Director Board of Directors

    2020

New Rhein Healthcare Investors

2018

  • Managing Partner and Chief Medical Officer

    2018

NT
Neuraptive Therapeutics

2018

  • Director Board of Directors

    2018

Travecta Therapeutics

2021 - 2022

  • Director Board of Directors

    2021 - 2022

NI
Neurotrope Inc.

2018 - 2020

  • Director Board of Directors

    2018 - 2020

RT
Realm Therapeutics, Inc.

2016 - 2019

  • Director Board of Directors

    2016 - 2019

Corium

2014 - 2018

  • Director Board of Directors

    2014 - 2018

NT
Nektar Therapeutics

2014 - 2017

  • Head of Development & Chief Medical Officer

    2014 - 2017